C12Q 2600/158
Expression markers
C12Q2600/158 (Expression markers) appears on 8,751 US grants and 19,875 published applications in this corpus.
Search patents in C12Q- Granted patents
- 8,751
- Published applications
- 19,875
- Assignees
- 5,081
- Inventors
- 30,050
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1987 | 2 | 0 |
| 1988 | 0 | 0 |
| 1989 | 2 | 0 |
| 1990 | 5 | 0 |
| 1991 | 11 | 0 |
| 1992 | 6 | 0 |
| 1993 | 23 | 0 |
| 1994 | 15 | 0 |
| 1995 | 15 | 0 |
| 1996 | 34 | 0 |
| 1997 | 61 | 0 |
| 1998 | 81 | 0 |
| 1999 | 105 | 0 |
| 2000 | 107 | 0 |
| 2001 | 111 | 32 |
| 2002 | 127 | 309 |
| 2003 | 107 | 1527 |
| 2004 | 106 | 465 |
| 2005 | 94 | 524 |
| 2006 | 151 | 590 |
| 2007 | 236 | 530 |
| 2008 | 270 | 479 |
| 2009 | 183 | 653 |
| 2010 | 297 | 684 |
| 2011 | 286 | 778 |
| 2012 | 257 | 707 |
| 2013 | 246 | 764 |
| 2014 | 296 | 797 |
| 2015 | 334 | 1137 |
| 2016 | 377 | 1222 |
| 2017 | 489 | 1131 |
| 2018 | 539 | 959 |
| 2019 | 673 | 914 |
| 2020 | 594 | 939 |
| 2021 | 530 | 886 |
| 2022 | 506 | 929 |
| 2023 | 440 | 937 |
| 2024 | 400 | 819 |
| 2025 | 388 | 641 |
| 2026 | 247 | 522 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Spatially encoded biological assays6 Oct 2026US 12,753,431 B2Prognosys Biosciences, Inc.
- Methods of isolating T cells and T-cell receptors from peripheral blood by single-cell analysis for immunotherapy6 Oct 2026US 12,753,437 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- DNA methylation biomarkers of post-partum depression risk6 Oct 2026US 12,753,439 B2The Johns Hopkins University
- Biomarkers of renal osteodystrophy type6 Oct 2026US 12,753,440 B2The Trustees of Columbia University in the City of New York
- Signature miRNA to predict neonatal opioid withdrawal syndrome (NOWS)6 Oct 2026US 12,753,442 B2The Texas A&M University Systems
- Methods of treating inflammatory diseases8 Oct 2026US 2026/0308246 A1Boehringer Ingelheim International GmbH
- Methods and systems for detecting genetic variants8 Oct 2026US 2026/0308677 A1Guardant Health, Inc.
- Microrna as a diagnostic tool and for developing advanced therapies of amyotrophic lateral sclerosis (als) with bulbar onset8 Oct 2026US 2026/0308682 A1Consiglio Nazionale Delle Ricerche
- Methods for cancer detection and monitoring8 Oct 2026US 2026/0308683 A1Natera, Inc.
- Biomarker for prediction of immunotherapy outcomes and precision treatment strategies and uses thereof8 Oct 2026US 2026/0308688 A1Ohio State Innovation Foundation
Most cited
By later US patents
- Digital amplification685US 6,440,706 B1The Johns Hopkins University · 2002
- Digital amplification430US 6,753,147 B2The Johns Hopkins University · 2004
- Non-invasive fetal genetic screening by digital analysis369US 7,888,017 B2The Board of Trustees of the Leland Stanford Junior University · 2011
- Determination of fetal aneuploidies by massively parallel DNA sequencing361US 8,008,018 B2The Board of Trustees of the Leland Stanford Junior University · 2011
- Methods for blocking the expression of specifically targeted genes334US 5,491,133 AUniversity of Iowa Research Foundation · 1996